A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Clinical trial NCT00840645 · COMPLETED

Trial details

NCT number: NCT00840645
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2008-12-01
Primary completion: 2010-03-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.